Perspective Therapeutics, Inc. (CATX) › Cash & EquivalentsPerspective Therapeutics, Inc. (CATX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $1.68M2011: $2.11M2012: $2.67M2013: $2.90M2014: $7.68M2015: $5.23M2016: $10.14M2017: $5.93M2018: $2.60M2019: $5.33M2020: $2.39M2021: $63.83M2022: $20.99M2023: $9.24M2024: $61.58M2025: $30.63M$30.63M2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$30.63M-50.3%2024$61.58M+566.6%2023$9.24M-56.0%2022$20.99M-67.1%2021$63.83M+2568.4%2020$2.39M-55.1%2019$5.33M+104.8%2018$2.60M-56.2%2017$5.93M-41.5%2016$10.14M+94.0%2015$5.23M-31.9%2014$7.68M+164.8%2013$2.90M+8.5%2012$2.67M+26.5%2011$2.11M+25.8%2010$1.68M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share